Related Experiment Video

Updated: Aug 16, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

[Invasive pulmonary aspergillesis]

G A Kliasova, N A Petrova, E N Parovichnikova

    Terapevticheskii Arkhiv
    |August 25, 2005
    PubMed
    Abstract

    Insights

    Invasive pulmonary aspergillosis (IPA) therapy yielded a 56% lethality rate with amphotericin B. Early diagnosis and voriconazole administration may reduce mortality in IPA patients.

    Area of Science:

    • Medical Mycology
    • Infectious Diseases
    • Pulmonology

    Background:

    • Invasive pulmonary aspergillosis (IPA) is a serious fungal infection, particularly in immunocompromised patients.
    • This study reviews IPA cases treated between 2000 and 2005 at a single medical center.

    Purpose of the Study:

    • To evaluate the therapeutic outcomes of invasive pulmonary aspergillosis (IPA).
    • To assess the effectiveness of different antifungal agents and treatment strategies.

    Main Methods:

    • Diagnosis of IPA followed international criteria.
    • Data collected included patient demographics, underlying conditions, diagnostic methods, and treatment regimens.
    • Treatment outcomes, including cure rates and lethality, were analyzed.

    Main Results:

    • IPA was diagnosed in 50 cases, with acute leukemia being the most common underlying condition (54%).
    • Mortality due to IPA was 56%, with 90-day survival at 47%.
    • Amphotericin B showed 29% effectiveness, while voriconazole and caspofungin had higher response rates in limited cases.

    Conclusions:

    • High lethality (56%) was observed with amphotericin B as the primary therapy for IPA.
    • Early diagnosis and prompt initiation of voriconazole are crucial for reducing IPA-related mortality.
    • Further multicenter studies are needed to establish optimal combined antifungal therapy protocols.

    More Related Videos

    Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

    Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

    Published on: March 9, 2018

    Related Concept Videos

    Fungal Phylum Ascomycota01:28

    Fungal Phylum Ascomycota

    Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...